Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II

Gustave Roussy, Cancer Campus, Grand Paris · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
pancreatic neuroendocrine carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 904104
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.